Diagnostics Market Research Reports & Industry Analysis

The global diagnostics industry plays a critical role in disease prevention, detection, and treatment across a wide range of medical fields—and it’s also a big business with significant opportunities for growth and innovation. As the industry continues to change, staying up to date on the latest trends and insights is essential.

New Diagnostics Industry Reports Produced by Industry Experts

To help organizations understand the market on a deeper level and better navigate the shifting business landscape, MarketResearch.com offers a wide range of diagnostics market research reports. These studies cover both the in vitro diagnostics and medical imaging segments, providing information on market sizing, growth forecasts, market share, mergers and acquisitions, new product development, competitive analysis, and corporate profiling. With coverage of disruptive trends and emerging technologies, our reports give you the knowledge you need to stay ahead of market changes.

What Are the Benefits of Using MarketResearch.com?

  • At MarketResearch.com, we understand the value of timely and reliable research. With over 20 years of experience in the field of market research, we have become a leading source of insights and analysis.
  • We bring together reports from hundreds of leading firms, making it easy to find the information you need in one place.
  • Our knowledgeable research specialists have worked closely with many top diagnostics industry companies and can offer personalized assistance to help you find reports that fit your research requirements.
  • With our comprehensive coverage and expert analysis, you will be better positioned to gain a competitive edge in the global diagnostics industry.
...Show More ...Show Less


Diagnostics Industry Research & Market Reports

  • Cholesterol Testing

    ... CAGR of 4.4% over the analysis period 2024-2030. Diagnostic Centers End-Use, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$11.6 Billion by the end of the ... Read More

  • Flow Cytometry Products and Services

    ... Billion by 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Cell-Based Flow Cytometry Technology, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach ... Read More

  • Spectroscopy Equipment and Accessories

    ... 2030, growing at a CAGR of 2.8% over the analysis period 2024-2030. Molecular Spectroscopy, one of the segments analyzed in the report, is expected to record a 3.0% CAGR and reach US$7.6 Billion by the ... Read More

  • Microfluidics Market by Product (Chip, Sensor, Valve, Pump, Needle), Material (Silicon, Polymer), Application (Diagnostics (Clinical, PoC), Research (Proteomic, Genomics, Cell), Therapeutics (Drug Delivery, Wearables)), End User- Global Forecast to 2029

    ... to a number of important factors. The growing requirement for point-of-care diagnostics is one of an important factor. The necessity for fast and accurate diagnosis has risen due to the increase in chronic diseases like ... Read More

  • Medical Microbiology Testing Technologies

    ... 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Respiratory Diseases Indication, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$1.4 Billion by ... Read More

  • Testing and Analysis Services

    ... 2030, growing at a CAGR of 5.6% over the analysis period 2024-2030. Elemental Analysis, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$12.4 Billion by the ... Read More

  • Toxicology Testing Services

    ... at a CAGR of 8.4% over the analysis period 2024-2030. In Vivo Method, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$10.2 Billion by the end ... Read More

  • Systemic Radiotherapy

    ... CAGR of 4.0% over the analysis period 2024-2030. Hospitals End-Use, one of the segments analyzed in the report, is expected to record a 4.1% CAGR and reach US$919.6 Million by the end of the analysis ... Read More

  • Brachytherapy

    ... 4.3% over the analysis period 2024-2030. High Dose Rate Brachytherapy, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$1.6 Billion by the end of the analysis ... Read More

  • Testing Laboratories

    ... CAGR of 7.2% over the analysis period 2024-2030. The U.S. Market is Estimated at US$30.0 Billion While China is Forecast to Grow at 9.6% CAGR The Testing Laboratories market in the U.S. is estimated at ... Read More

  • Linear Motion Systems

    ... at a CAGR of 6.1% over the analysis period 2024-2030. Multi-Axis Linear Motion Systems, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$2.9 Billion by the ... Read More

  • Portable Ultrasound Equipment

    ... at a CAGR of 5.9% over the analysis period 2024-2030. Cart / Trolley-Based Ultrasound Equipment, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$2.4 Billion by ... Read More

  • Hybrid Operating Rooms

    ... at a CAGR of 12.2% over the analysis period 2024-2030. Intraoperative Diagnostic Imaging Systems, one of the segments analyzed in the report, is expected to record a 12.9% CAGR and reach US$1.3 Billion by the ... Read More

  • Hyperspectral Imaging Systems

    ... at a CAGR of 18.7% over the analysis period 2024-2030. Hyperspectral Imaging Cameras, one of the segments analyzed in the report, is expected to record a 19.6% CAGR and reach US$53.0 Billion by the end ... Read More

  • Immunoprotein Diagnostic Testing

    ... at a CAGR of 5.2% over the analysis period 2024-2030. Immunoglobulin Diagnostic Testing, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$6.4 Billion by the end ... Read More

  • Infectious Disease Diagnostics

    ... at a CAGR of 5.5% over the analysis period 2024-2030. Diagnostic Assays & Reagents, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$25.8 Billion by the ... Read More

  • Intraoperative Imaging

    ... CAGR of 4.4% over the analysis period 2024-2030. Mobile C-Arms, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More

  • Lab Automation Equipment and Software

    ... Billion by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Automated Workstations, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$2.5 Billion ... Read More

  • Multiplex Detection Immunoassays

    ... at a CAGR of 3.4% over the analysis period 2024-2030. Protein-Based Multiplex Technique, one of the segments analyzed in the report, is expected to record a 3.6% CAGR and reach US$2.4 Billion by the end ... Read More

  • Multiplex Assays

    ... CAGR of 6.4% over the analysis period 2024-2030. Multiplex Assay Consumables, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and reach US$3.7 Billion by the end of the ... Read More

  • Nucleic Acid Labeling

    ... at a CAGR of 7.5% over the analysis period 2024-2030. Nucleic Acid Labeling Reagents, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$2.4 Billion by the ... Read More

  • Oncology Molecular Diagnostics

    ... at a CAGR of 11.1% over the analysis period 2024-2030. Breast Cancer Indication, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$2.9 Billion by the end ... Read More

  • MRI Compatible Pacemaker

    ... at a CAGR of 4.0% over the analysis period 2024-2030. Arrhythmias Application, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$1.5 Billion by the end of ... Read More

  • Acute Ischemic Stroke Diagnosis and Treatment

    ... reach US$3.1 Billion by 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Computed Tomography Diagnosis, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and ... Read More

  • Bio-MEMS

    ... 16.7% over the analysis period 2024-2030. Microfluidic Chips, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$27.4 Billion by the end of the analysis period. Growth ... Read More

Cookie Settings